[1]
Z. Siami, D. Dehghan, A. . Khavandegar, M. Lak, and M. Bakhtiyari, “Efficacy and Safety of Atazanavir/Ritonavir Versus Lopinavir/Ritonavir in Hospitalized COVID-19 Patients: A Randomized Clinical Trial”, Iran. Red. Crescent. Med. J., vol. 24, no. 5, May 2022.